ENGLISHHOMECONTACT USSITEMAP

제품정보
Kyongshin PRODUCT

Zymo Research

Bertin

Saphymo (Bertin)

Berthold

Serumwerk

Biocomp

Capitalbio

Arrayjet

PolyAn

Hudson Robotics

ABER instrument

Arthus Biosystems

BioChain

Povair

BIOREAGENT(Bertin)

BIOREAGENT(Bertin)
▪ HOME>제품정보>BIOREAGENT(Bertin)
Prion Protein Monoclonal Antibody - Sha31
Antibodies - Monoclonal Antibodies

Size: 200 µg
서한형 대리
010-8832-6303

제품소개

Territorial Availability: Available worldwide directly through Bertin or your local distributor
Synonyms:
  • Prion Protein Monoclonal Antibody - Sha31
Correlated keywords:
  • proteins
  • mad
  • cow
  • diseases
  • bovine
  • spongiform
  • encephalopathy
  • scrapie
  • Creutzfeldt-jakob
  • neurodegeneration
  • antibodies
  • antisera
  • antiserum
  • neurochemistry
  • neuroscience
  • spi-bio
  • spibio
  • A03200
Product Overview:
Prion Protein (PrP) and namely its abnormal isoform, partially resistant to proteinase K (PrPres), is the only specific molecular marker of the Transmissible Spongiform Encephalopathies (TSEs) such as Bovine Spongiform Encephalopathie (BSE) or its human form, the New Variant of Creutzfeld-Jakob disease.
This antibody recognises the human protein sequence within amino acids 145-152 (human numbering).

Size200 µg
ShippingDry Ice
HostMouse
AntigenThis anti-prion protein (PrP) monoclonal antibody was raised against proteinase K treated and non-denatured scrapie-associated fibrils from Syrian hamster infected brain (263K).
CloneSha 31
IsotypeIgG1k
Application(s)

Reconstitute the content of the vial in 1 mL of water.

For EIA, the optimal working dilution must be determined empirically (currently be-tween 0.1 and 1 µg/mL). For western blot analysis of PrPc, dilute the antibody to a final concentration of 1 µg/mL.

Specificity
Application MediaReconstitute the content of the vial in 1 mL of water.
Formulationlyophilized IgG with BSA
Custom Code3822000000
UNSPSC code12352203

Vulin J, Biacabe AG, Cazeau G, Calavas D, and Baron T Molecular typing of protease-resistant prion protein in transmissible spongiform encephalopathies of small ruminants, France, 2002-2009. Emerg Infect Dis, Jan 2011; 17(1): 55-63.

Morel N., Simon S., Frobert Y., Volland H., Mourton-Gilles C., Negro A., Sorgato M.C., Creminon C., and Grassi J. Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrils.

J Biol Chem, 279 :30143-9 (2004)

Notari S., Capellari S., Langeveld J., Giese A., Strammiello R., Gambetti P., Kretzschmar H.A., and Parchi P. A refined method for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt-Jakob disease is not the rule.

Lab Invest 87, 1103-12 (2007).

Feraudet C, Morel N, Simon S, Volland H., Frobert Y., Creminon C., Vilette D., Lehmann S., and Grassi J. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.

J Biol Chem 2005, 280:11247–11258


주문정보

CAT.No 품명 규격 비고
A03213 Prion Protein Monoclonal Antibody - Sha31 200 µg Antibodies - Monoclonal Antibodies